David R Croucher - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

David R Croucher

Showing results (51-60 of 60) with videos related to

Pageof 6

Sort By:

You have reached the last page of results.This site can display upto 60 results.

Science Advances|March 3, 2023

Memory of stochastic single-cell apoptotic signaling promotes chemoresistance in neuroblastomaJordan F Hastings, Sharissa L Latham, Alvin Kamili, et al.

Nature Communications|August 14, 2019

CAF hierarchy driven by pancreatic cancer cell p53-status creates a pro-metastatic and chemoresistant environment via perlecanClaire Vennin, Pauline Mélénec, Romain Rouet, et al.

Cell Reports|January 4, 2016

Intravital FRAP Imaging using an E-cadherin-GFP Mouse Reveals Disease- and Drug-Dependent Dynamic Regulation of Cell-Cell Junctions in Live TissueZahra Erami, David Herrmann, Sean C Warren, et al.

Science Translational Medicine|July 27, 2018

Inhibition of activin signaling in lung adenocarcinoma increases the therapeutic index of platinum chemotherapyKieren D Marini, David R Croucher, Rachael A McCloy, et al.

Cell Reports|September 15, 2021

Optimizing metastatic-cascade-dependent Rac1 targeting in breast cancer: Guidance using optical window intravital FRET imagingAlessia Floerchinger, Kendelle J Murphy, Sharissa L Latham, et al.

Science Advances|May 1, 2023

Monitoring AKT activity and targeting in live tissue and disease contexts using a real-time Akt-FRET biosensor mouseJames R W Conway, Sean C Warren, Young-Kyung Lee, et al.

Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|April 11, 2024

Tumor Biomechanics Alters Metastatic Dissemination of Triple Negative Breast Cancer via Rewiring Fatty Acid MetabolismElysse C Filipe, Sipiththa Velayuthar, Ashleigh Philp, et al.

Nature Cancer|August 28, 2023

A first-in-class pan-lysyl oxidase inhibitor impairs stromal remodeling and enhances gemcitabine response and survival in pancreatic cancerJessica L Chitty, Michelle Yam, Lara Perryman, et al.

Science Advances|March 12, 2025

Targeting the NPY/NPY1R signaling axis in mutant p53-dependent pancreatic cancer impairs metastasisCecilia R Chambers, Supitchaya Watakul, Peter Schofield, et al.

Science Advances|July 3, 2024

Temporally resolved proteomics identifies nidogen-2 as a cotarget in pancreatic cancer that modulates fibrosis and therapy responseBrooke A Pereira, Shona Ritchie, Cecilia R Chambers, et al.

Pageof 6

Search research articles

Showing results (51-60 of 60) with videos related to

Sort By:

Pageof 6

You have reached the last page of results.This site can display upto 60 results.

Science Advances|March 3, 2023

Memory of stochastic single-cell apoptotic signaling promotes chemoresistance in neuroblastomaJordan F Hastings, Sharissa L Latham, Alvin Kamili, et al.

Nature Communications|August 14, 2019

CAF hierarchy driven by pancreatic cancer cell p53-status creates a pro-metastatic and chemoresistant environment via perlecanClaire Vennin, Pauline Mélénec, Romain Rouet, et al.

Cell Reports|January 4, 2016

Intravital FRAP Imaging using an E-cadherin-GFP Mouse Reveals Disease- and Drug-Dependent Dynamic Regulation of Cell-Cell Junctions in Live TissueZahra Erami, David Herrmann, Sean C Warren, et al.

Science Translational Medicine|July 27, 2018

Inhibition of activin signaling in lung adenocarcinoma increases the therapeutic index of platinum chemotherapyKieren D Marini, David R Croucher, Rachael A McCloy, et al.

Cell Reports|September 15, 2021

Optimizing metastatic-cascade-dependent Rac1 targeting in breast cancer: Guidance using optical window intravital FRET imagingAlessia Floerchinger, Kendelle J Murphy, Sharissa L Latham, et al.

Science Advances|May 1, 2023

Monitoring AKT activity and targeting in live tissue and disease contexts using a real-time Akt-FRET biosensor mouseJames R W Conway, Sean C Warren, Young-Kyung Lee, et al.

Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|April 11, 2024

Tumor Biomechanics Alters Metastatic Dissemination of Triple Negative Breast Cancer via Rewiring Fatty Acid MetabolismElysse C Filipe, Sipiththa Velayuthar, Ashleigh Philp, et al.

Nature Cancer|August 28, 2023

A first-in-class pan-lysyl oxidase inhibitor impairs stromal remodeling and enhances gemcitabine response and survival in pancreatic cancerJessica L Chitty, Michelle Yam, Lara Perryman, et al.

Science Advances|March 12, 2025

Targeting the NPY/NPY1R signaling axis in mutant p53-dependent pancreatic cancer impairs metastasisCecilia R Chambers, Supitchaya Watakul, Peter Schofield, et al.

Science Advances|July 3, 2024

Temporally resolved proteomics identifies nidogen-2 as a cotarget in pancreatic cancer that modulates fibrosis and therapy responseBrooke A Pereira, Shona Ritchie, Cecilia R Chambers, et al.

Pageof 6